Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2079 | 4804 | 33.7 | 76% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
623 | 10035 | THROMBOTIC THROMBOCYTOPENIC PURPURA//RIBOSOME INACTIVATING PROTEINS//ADAMTS 13 |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
1242 | 2666 | THROMBOTIC THROMBOCYTOPENIC PURPURA//ADAMTS 13//TTP |
4435 | 1713 | SHIGA TOXIN//HEMOLYTIC UREMIC SYNDROME//SHIGA TOXIN B SUBUNIT |
24607 | 257 | UF SIDA//KODECYTE//ESA CNRS 6033 |
28482 | 168 | T ACTIVATION//POLYAGGLUTINATION//ERYTHROCYTE CHARGE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | THROMBOTIC THROMBOCYTOPENIC PURPURA | Author keyword | 864 | 75% | 13% | 632 |
2 | ADAMTS 13 | Author keyword | 552 | 76% | 8% | 389 |
3 | HEMOLYTIC UREMIC SYNDROME | Author keyword | 387 | 54% | 10% | 503 |
4 | THROMBOTIC MICROANGIOPATHY | Author keyword | 128 | 41% | 5% | 244 |
5 | TTP | Author keyword | 127 | 52% | 4% | 173 |
6 | SHIGA TOXIN | Author keyword | 97 | 39% | 4% | 197 |
7 | UPSHAW SCHULMAN SYNDROME | Author keyword | 86 | 96% | 1% | 26 |
8 | THROMBOTIC THROMBOCYTOPENIC PURPURA TTP | Author keyword | 69 | 75% | 1% | 49 |
9 | VON WILLEBRAND FACTOR CLEAVING PROTEASE | Author keyword | 67 | 85% | 1% | 35 |
10 | MICROANGIOPATHIC HEMOLYTIC ANEMIA | Author keyword | 52 | 62% | 1% | 53 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FACTOR CLEAVING PROTEASE | 947 | 69% | 17% | 814 |
2 | HEMOLYTIC UREMIC SYNDROME | 470 | 27% | 31% | 1510 |
3 | MICROANGIOPATHIES | 302 | 83% | 4% | 172 |
4 | THROMBOTIC THROMBOCYTOPENIC PURPURA | 245 | 34% | 12% | 597 |
5 | UPSHAW SCHULMAN SYNDROME | 149 | 86% | 2% | 75 |
6 | TTP | 145 | 70% | 2% | 120 |
7 | ADAMTS13 ACTIVITY | 123 | 78% | 2% | 80 |
8 | ADAMTS 13 | 122 | 52% | 3% | 164 |
9 | VONWILLEBRAND FACTOR MULTIMERS | 97 | 55% | 3% | 122 |
10 | PLASMA EXCHANGE | 83 | 18% | 9% | 431 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Mechanisms of disease - Thrombotic microangiopathies | 2002 | 643 | 97 | 80% |
Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura | 2008 | 205 | 58 | 95% |
Syndromes of Thrombotic Microangiopathy | 2014 | 27 | 57 | 53% |
The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura | 2015 | 3 | 25 | 96% |
Shiga toxins - from cell biology to biomedical applications | 2010 | 145 | 160 | 73% |
VWF excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TIP | 2015 | 4 | 121 | 53% |
How I treat patients with thrombotic thrombocytopenic purpura: 2010 | 2010 | 101 | 46 | 76% |
How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome | 2014 | 11 | 35 | 69% |
ADAMTS13 and von Willebrand Factor in Thrombotic Thrombocytopenic Purpura | 2015 | 2 | 86 | 86% |
Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan | 2011 | 34 | 59 | 97% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BLOOD TRANSFUS MED | 40 | 46% | 1.4% | 65 |
2 | SERV HEM HE E | 15 | 88% | 0.1% | 7 |
3 | PATOGENESIS INMUNOL PROC INFECCIOSOS | 9 | 83% | 0.1% | 5 |
4 | MOL INFECTIOL | 9 | 39% | 0.4% | 18 |
5 | CENT HEMATOL | 9 | 14% | 1.2% | 59 |
6 | UF SIDA | 8 | 70% | 0.1% | 7 |
7 | TRAF SIGNALISAT | 8 | 60% | 0.2% | 9 |
8 | REFERENCE MICROANGIOPATHIES THROMBOT | 8 | 100% | 0.1% | 5 |
9 | INFECT IMMUN INJURY REPAIR | 7 | 48% | 0.2% | 11 |
10 | FISIOPATOGENIA | 7 | 36% | 0.3% | 16 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000028545 | STEC//EPEC//UROGUANYLIN |
2 | 0.0000013192 | RIBOSOME INACTIVATING PROTEINS//RICIN//TRICHOSANTHIN |
3 | 0.0000011574 | HAEMOPHILIA//HAEMOPHILIA A//VON WILLEBRAND DISEASE |
4 | 0.0000010530 | LDL APHERESIS//LOW DENSITY LIPOPROTEIN APHERESIS//APHERESIS |
5 | 0.0000007648 | COMPLEMENT//MANNOSE BINDING LECTIN//PAROXYSMAL NOCTURNAL HEMOGLOBINURIA |
6 | 0.0000007536 | IMMUNE THROMBOCYTOPENIA//IDIOPATHIC THROMBOCYTOPENIC PURPURA//IMMUNE THROMBOCYTOPENIC PURPURA |
7 | 0.0000007413 | POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME//REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME//HYPERTENSIVE ENCEPHALOPATHY |
8 | 0.0000007408 | PURPURA FULMINANS//SYMMETRICAL PERIPHERAL GANGRENE//CARCINOCYTHEMIA |
9 | 0.0000006668 | TINU SYNDROME//ACUTE INTERSTITIAL NEPHRITIS//PROPYLTHIOURACIL |
10 | 0.0000005868 | ANTIPHOSPHOLIPID SYNDROME//ANTIPHOSPHOLIPID ANTIBODIES//LUPUS ANTICOAGULANT |